Pharmcore Inc. dba Hallandale Pharmacy

Warning LetterClosed

United StatesFEI 3014480778Issued Mar 11, 2020

View FDA's record for FEI 3014480778

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3014480778.

Violations0

Issue DateMar 11, 2020

Product TypeDrugs

StatusClosed

Letter Details

Firm: Pharmcore Inc. dba Hallandale Pharmacy
Location: United States
FEI Number: 3014480778
Country: United States
Issue Date: March 11, 2020
Issuing Office: N/A
Product Type: Drugs
Status: Closed

Summary

Based on limited metadata, the FDA issued a warning letter to Pharmcore Inc. dba Hallandale Pharmacy on March 11, 2020, regarding drug products. Without access to the full warning letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The letter falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. Additional documentation would be needed to identify the particular compliance issues cited.

Pharmcore Inc. dba Hallandale Pharmacy FDA Warning Letter, March 11, 2020